ICD-10-CM Billable Code

M48.17

Ankylosing hyperostosis [Forestier], lumbosacral region

Clinical Classification Guidelines

Medical Intelligence & Overview

Ankylosing hyperostosis, also known as Forestier's disease, is a condition characterized by abnormal growths of new bone along the sides of the vertebrae. When it affects the lumbosacral region, the lower part of the spine is involved. This condition can lead to stiffness and reduced mobility in the lower back, impacting daily activities and quality of life. Recognized under ICD-10 code M48.17, understanding this condition helps in managing symptoms and improving spinal health.

Causes & Symptoms

Clinical Causes: Degenerative changes associated with aging Genetic predisposition, with possible links to conditions like ankylosing spondylitis Chronic mechanical stress or injury to the spine Metabolic or inflammatory factors influencing abnormal bone growth Possibly linked to other spondyloarthropathies or systemic inflammatory diseases

Key Symptoms: Persistent stiffness in the lower back, especially upon waking or after periods of inactivity Reduced flexibility of the lumbar spine Localized pain or discomfort, which may worsen with movement Rarely, nerve compression leading to numbness or tingling in the legs Possible development of a forward-stooped posture as the condition progresses

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a detailed medical history and physical examination, focusing on spinal mobility. Imaging studies are paramount and may include: - X-rays revealing characteristic bony outgrowths along the anterior of the lumbar vertebrae - CT scans providing detailed bone structure visualization - MRI to assess any nerve compression or soft tissue involvement Laboratory tests are usually not specific but may be conducted to rule out other inflammatory or degenerative conditions.

Treatment Protocols: While there is no cure for ankylosing hyperostosis, various strategies can help manage symptoms and maintain mobility: - Physical therapy to improve flexibility and strengthen supporting muscles - Nonsteroidal anti-inflammatory drugs (NSAIDs) to reduce inflammation and pain - Regular exercise tailored to individual capabilities - In severe cases, surgical intervention may be considered to decompress nerves or correct severe deformities Long-term management often includes routine monitoring and adjustment of treatment plans to address any progression or new symptoms.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M48.17 a billable ICD-10 code?
Yes, M48.17 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M48.17?
Clinical documentation must specify the nature of Ankylosing hyperostosis [Forestier], lumbosacral region and any associated comorbidities for accurate reporting.

Cite this Clinical Reference